Cardio Diagnostics Holdings, Inc. Income Statement
CDIO|4 years of annual SEC 10-K data (FY2022-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
Cardio Diagnostics Holdings, Inc. reported $34,890 in revenue and $8M in net loss for FY2025. Revenue has grown at a 238.3% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $34.9K | $17.1K | $950 | $901 |
| SG&A Expense | $6.9M | $6.9M | $4.4M | $470.6K |
| R&D Expense | $228.0K | $145.2K | $40.4K | $31.5K |
| Operating Income | -$8.4M | -$7.2M | -$4.5M | -$620.4K |
| Interest Expense | $18.6K | $6.7M | $6.7M | - |
| Income Tax | - | - | - | $0 |
| Net Income | -$8.4M | -$8.4M | -$4.7M | -$620.4K |
| EPS (Basic) | -$9.35 | -$0.66 | -$1.51 | -$0.53 |
| EPS (Diluted) | -$9.35 | -$0.66 | -$1.51 | -$0.53 |
| Shares Outstanding | 1.5M | 20.5M | 9.5M | 1.2M |
| Operating Margin | -23977.9% | -42440.4% | -478784.3% | -68862.1% |
| Profit Margin | -24028.2% | -49087.8% | -490630.0% | -68862.1% |